USAD22: Art History and Appreciation (Mid Semester Exam)

12
CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22 PART A Instruction: Answer ALL questions 1. Cave paintings were coloured using earth and mineral pigments. Earth pigments are the colours found in rock and soils EXCEPT a. Ocher b. Lapis Lazuli c. Sienna d. Umber 2. In ancient Greek, Mesopotamia means “the land between two rivers”. What are the names of the two rivers? a. Nile and Tigris b. Euphrates and Tigris c. Nile and Euphrates d. Tigris and Indus 3. ÇatalHöyük, is one of the famous Neolithic town located in a. Mesopotamia b. Babylon c. Anatolia d. Damascus 1

Transcript of USAD22: Art History and Appreciation (Mid Semester Exam)

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

PART A

Instruction: Answer ALL questions

1. Cave paintings were coloured using earth and mineral pigments. Earth pigments

are the colours found in rock and soils EXCEPT

a. Ocher

b. Lapis Lazuli

c. Sienna

d. Umber

2. In ancient Greek, Mesopotamia means “the land between two rivers”. What are

the names of the two rivers?

a. Nile and Tigris

b. Euphrates and Tigris

c. Nile and Euphrates

d. Tigris and Indus

3. ÇatalHöyük, is one of the famous Neolithic town located in

a. Mesopotamia

b. Babylon

c. Anatolia

d. Damascus

1

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

4. These are the three civilization of the old world EXCEPT

a. Aegean

b. Egyptian

c. Mesopotamia

d. Indus Valley

Figure 1

5. What is the name of this structure? (Refer to figure 1)

a. Ziggurat

b. Pyramid

c. Temple

d. Mastaba

2

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

6. On the top of this structure, there is a temple called _______. (Refer to figure 1)

a. Shamash

b. Shaman

c. Shakaru

d. Stonehenge

7. These are the sacred animal in ancient Egyptian religion EXCEPT

a. Elephant

b. Cats

c. Falcon

d. Lion

8. What is the meaning of “mastaba”?

a. House of the Pharaohs

b. House of fertility

c. House of eternity

d. House of Gods

3

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

Figure 2

9. What is the name of the instrument above? (Refer to figure 2)

a. Guitar

b. Harp

c. Ukulele

d. Violin

10.This instrument was found in ______________. (Refer to figure 2)

a. Saqqara, Egypt

b. Knossos, Crete

c. Athens, Greece

d. Ur, Iraq

4

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

11.The panel beneath this instrument has a strange little picture which is called

______________ motifs. (Refer to figure 2)

a. Fantasy

b. Gilgamesh

c. Akkadian

d. Fairytales

12._____________ is known as the goddess of victory in war and wisdom.

a. Venus

b. Aphrodite

c. Athena

d. Hera

13.______________ is known as the skillful craftsman who designs Temple on

Crete and Memphis in Egypt.

a. Imhotep

b. Dedalus

c. Iktinos

d. Pericles

5

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

Figure 3

14.What is the purpose of this structure? (Refer to Figure 3)

a. Tomb

b. House

c. Museum

d. Temple

Instruction: Match the civilization and the structure

Mesopotamia • • Pyramid

Egyptian • • Citadel

Indus • • Mohenjo-Daro

Aegean • • Mayan

6

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

Greek • • Ziggurat

Mesoamerica • • Parthenon

(20 marks)

PART B

Instruction: This part consists of FOUR (4) essay questions. Answer only ONE (1)

question.

QUESTION 1

There are several Venus figurines found in the prehistoric era, describe the following

7

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

artifacts.

i. Women from Willendorf

ii. Mother Goddess from Laussel

(20 marks)

QUESTION 2

The Great Sphinx of Giza is the oldest monumental sculpture built by the ancient

Egyptians. Elaborate the structure of the Great Sphinx of Giza.

(20 marks)

QUESTION 3

Describe the differences between Ziggurat and Pyramid.

(20 marks)

QUESTION 4

The Aegean art is different compare to Mesopotamia and Egyptian art. Elaborate the

characteristics of the Aegean art.

(20 marks)

8

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

9

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

10

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

11

CONFIDENTIAL ACTP/ADFP/MAR2015/USAD22

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

___________________________________________________________________

12